-
No events are scheduled in this topic at this time. Click the RSS icon above and bookmark our RSS feed to learn about future events.
Tuesday, March 12, 2013 | 8:30 AM - 4:30 PM
Speakers: Sheng Bi (Johns Hopkins University School of Medicine), Sheila Collins (Sanford-Burnham Medical Research Institute, Diabetes and Obesity Research Center), Abdul G. Dulloo (University of Fribourg), Vicente Gilsanz (Children's Hospital Los Angeles), Andrew C. Larner (Virginia Commonwealth University), David A. Price, Pfizer, Inc, Devanjan Sikder (Sanford-Burnham Medical Research Institute, Diabetes and Obesity Research Center), J. Enrique Silva (Tufts University School of Medicine), Bruce M Spiegelman (Dana-Farber Cancer Institute, Harvard Medical School), Anne-Ulrike Trendelenburg (Novartis Institutes for BioMedical Research, Yu-Hua Tseng (Joslin Diabetes Center, Harvard Medical School), Richard L. Veech (National Institute on Alcohol Abuse and Alcoholism/NIH)
This conference will present recent research exploring adipogenesis focusing on brown adipose tissue, and will explore its implications in diet-induced obesity.
June 26 - 27, 2012
Organizers: William G. Kerr (SUNY Upstate Medical University), Christina Mitchell (Monash University, Australia), and Christian Rommel (Intellikine)
Keynote Speaker: Lewis C. Cantley (Harvard Medical School)
Examine the role of Inositol Phospholipid (IP) signaling in cancer, metabolic, and inflammatory disease. This exploration of the specificity and interplay of diverse IP-modifying enzymes aims to identify novel approaches for therapeutic intervention.
Thursday, June 21, 2012 | 11:30 AM - 3:00 PM
Speaker: Arline Cohn
The Lyceum Society is comprised of the Academy's retired and semi-retired members. Talks cover various scientific fields. All Academy members are welcome.
June 11 - 12, 2012
Organizers: Sudhansu K. Dey (Cincinnati Children's Hospital Medical Center), Susan J. Fisher (University of California, San Francisco), and Jeffrey A. Whitsett (Cincinnati Children's Hospital Medical Center)
Keynote Speakers: Frederick Vom Saal (University of Missouri–Columbia) and Randy L. Jirtle (Duke University)
This 1.5-day conference will explore recent discoveries, challenges, and future research directions for understanding the complex gene–gene and gene–environment interactions responsible for fetal programming in utero and pre-term birth and the lasting adverse health effects.
|
-
Annals
Edited by Alvin C. Powers (Vanderbilt University, Nashville, Tennessee) and Rexford S. Ahima (University of Pennsylvania, Philadelphia, Pennsylvania)
In-depth review articles on timely topics in obesity and diabetes research.
Annals
Edited by William G. Kerr (SUNY Upstate Medical University, Syracuse, New York) and Sandra Fernandes (SUNY Upstate Medical University, Syracuse, New York)
This Annals issue presents recent research examining the role of inositol phospholipid signaling in both normal and disease-associated cellular physiology.
Volume 1280
Annals
Edited by Annals of the New York Academy of Sciences editorial staff
This Annals volume presents the following three meeting reports (1) Biomarkers in nutrition: new frontiers in research and application; (2) The new revolution in toxicology: The good, the bad, and the ugly; and (3) Neuroprotection after cerebral ischemia.
Volume 1278
Free online access provide by the Sackler Institute for Nutrition Science
eBriefing
Organizers: Howard Fillit (Alzheimer's Drug Discovery Foundation) and Jennifer Henry (The New York Academy of Sciences)
Vascular alterations are both a cause and a consequence of neuronal loss. This eBriefing presents current knowledge on the vascular connection to Alzheimer's pathogenesis and highlights novel approaches to intervention for therapeutic development.
Webinar Archive
October 27, 2009
What is the connection between dysregulated neuronal insulin signaling and Alzheimer's disease? In a recent Academy webinar, some researchers argued that the neurodegenerative disease should be considered a type of diabetes.
Translational Medicine Initiative
 The Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.
Learn more at www.nyas.org/TransMed.
|